Parallax Volatility Advisers
IOVA icon

Parallax Volatility Advisers’s Iovance Biotherapeutics IOVA Stock Holding History

Parallax Volatility Advisers’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,000
Closed -$504K – 2136
2024
Q1 		$504K Buy
+34,000
New +$396K ﹤0.01% 1404
2022
Q4 		– Sell
-137,500
Closed -$1.32M – 3066
2022
Q3 		$1.32M Buy
+137,500
New +$1.59M ﹤0.01% 1622
2021
Q4 		– Sell
-190,300
Closed -$4.69M – 2100
2021
Q3 		$4.69M Buy
+190,300
New +$4.48M ﹤0.01% 853
2021
Q1 		– Sell
-56,000
Closed -$2.6M – 1609
2020
Q4 		$2.6M Buy
56,000
+45,600
+438% +$1.81M ﹤0.01% 1176
2020
Q3 		$342K Sell
10,400
-16,800
-62% -$515K ﹤0.01% 2370
2020
Q2 		$744K Buy
+27,200
New +$894K ﹤0.01% 1851
2020
Q1 		– Sell
-40,000
Closed -$1.11M – 2585
2019
Q4 		$1.11M Buy
+40,000
New +$910K ﹤0.01% 1483
2016
Q1 		– Sell
-105,000
Closed -$811K – 3079
2015
Q4 		$811K Buy
105,000
+75,000
+250% +$520K ﹤0.01% 1352
2015
Q3 		$173K Buy
+30,000
New +$234K ﹤0.01% 1851

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Parallax Volatility Advisers's IOVA Position: Q1 2024 in Review

Parallax Volatility Advisers sold out of Iovance Biotherapeutics (IOVA) in Q1 2024, closing a stake of 11,977 shares — an estimated $139K sold.

Parallax Volatility Advisers first reported a position in IOVA in Q4 2017 and held it in 8 quarters. The position peaked at $301K in Q3 2020. 273 funds tracked by Wall St. Rank hold IOVA as of Q1 2024.

  • Parallax Volatility Advisers reported no remaining Iovance Biotherapeutics position as of Q1 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 11,977 Iovance Biotherapeutics shares in Q1 2024, an estimated $139K.
  • Parallax Volatility Advisers first reported a position in Iovance Biotherapeutics in Q4 2017 and held it in 8 quarters.
  • Parallax Volatility Advisers's Iovance Biotherapeutics position peaked at $301K in Q3 2020.
  • 273 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2024.

Based on Parallax Volatility Advisers's 13F filing for Q1 2024, filed 15 May 2024.